JavaScript is disabled for your browser. Some features of this site may not work without it.
TILLING : EMS mutagenesis in Epichloë endophytes and mutation screening using High Resolution Melting analysis and Next Generation Sequencing : this thesis is presented in partial fulfilment of the requirements for the degree of Master of Science (MSc) in Microbiology at Massey University, Palmerston North, New Zealand
Epichloë are fungal endophytes (family Clavicipitaceae) of pasture grasses of the sub family
poöideae. These endophytes live in symbiotic association with their hosts and confer
resistance to insect and animal herbivory through the production of bioactive secondary
metabolites (alkaloids) that are produced in planta. For a number of years endophyte research
has been focused at manipulating fungal genes responsible for production of alkaloids which
have toxic effects on livestock. However, the techniques used to date involve genetic
modification to delete genes responsible for alkaloid production and strict regulations around
genetically modified organisms in New Zealand prevent commercialisation of these
organisms. Traditional mutagenesis was not practical. To find mutations in secondary
metabolite pathways, the mutants had to be inoculated back into plants, which would have
been a laborious and time-consuming process. The aim of my research was to develop
Targeting Induced Local Lesions In Genomes (TILLING) methodology in Epichloë to
disrupt fungal secondary metabolite genes using Ethyl methanesulfonate (EMS) and screen
for mutations using high throughput screening techniques such as High Resolution Melting
(HRM) analysis and whole genome sequencing, MiSeq.
In order to carry out the mutagenesis, uninucleate propagules would be preferred but as most
of the filamentous fungi (including Epichloë) are multinucleate in nature, spores were
thought to be an ideal alternative for mutagenesis. However, many of the commercially used
Epichloë strains, such as AR1 and AR37, do not readily produce spores. Therefore an
alternative mutagenesis system using fungal protoplasts was investigated and employed.
EMS mutagenesis showed that the number of colonies derived from protoplasts after
mutagenesis declined steadily at a reproducible rate as measured by time-course of 0, 15, 30,
45 and 60 minutes to give LD50 values. At 60 minutes there was decline in the number of
colonies to the levels of 10% of the initial number. To determine the effectiveness of EMS as
a mutagen positive selection, using 5-Fluoroorotic acid (5-FOA), was also performed on the
mutagenized protoplasts to derive the mutation frequency of 6 mutations per 1000 mutants
compared to 0.002 mutations per 1000 for non-mutagenized protoplasts. This suggests a
3000-fold EMS-induced increase in the frequency of mutations.
Having established mutation frequency from the 5-FOA, positive selection and steady decline
in number of colonies from EMS mutagenesis, an EMS mutant library was screened using
next generation sequencing. . However, high throughput whole genome sequencing (MiSeq)
led to the detection of only three verifiable point mutations (1 in 10Mb). Microscopic
observations revealed that while individual protoplasts were largely (85%) uninucleate,
protoplasts typically formed clumps containing 15-30 protoplasts. In theory, multiple
nuclei would lead to an overestimation of the number of mutations since each nucleus would
accumulate different SNPs. However, MiSeq sequencing did not detect this, probably due to
being filtered out during bioinformatics processing. Thus if methods can be devised for
plating single protoplasts, EMS mutagenesis should be applicable to this system. TILLING
technology can be used to reduce the time for endophyte discovery and improvement. My
research demonstrated that this procedure, although very promising in terms of benefit to
fungal improvement, carries certain difficulties with it that we had to address such as
mutagenesis using protoplasts and subsequent mutation discovery. I succeeded in establishing
TILLING methodology for mutagenesis of E. festucae strain Fl1 as well as optimising
protocols to screen mutants.